Gilead Sciences Inc.

In News

US FDA approves Gilead's once-daily combination pill for HIV treatment - Reuters

Reuters - Aug 27, 2026

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens - Gilead Sciences

Gilead Sciences - Aug 27, 2026

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo - TipRanks

TipRanks - Aug 28, 2026

Wellington Management Group LLP Sells 838,308 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences - Business Wire

Business Wire - Aug 26, 2026

What Does Gilead Sciences (GILD) Gain From Its Expanded EU Breast Cancer Approval? - Yahoo Finance

Yahoo Finance - Aug 27, 2026

Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch

MarketWatch - Aug 28, 2026

Royal London Asset Management Ltd. Lowers Position in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Braun Stacey Associates Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Nissay Asset Management Corp Japan Boosts Position in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Rakuten Investment Management Inc. Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Beacon Pointe Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

MarketBeat - Aug 29, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment